Forbes -
18 Jul 2014 18:01
In trading on Friday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of NPS Pharmaceuticals (NPSP), up about 8.9% and shares of Immunogen (IMGN), up about 8% on the day.
Share this Article
Comment on this Article
Please to comment